Overall, MET effects of GRHL2 overexpression, EZH2 inhibition, and HDAC inhibition were limited in ovarian cancer cells with a full EMT state, as these cells may have additional mechanisms that would hinder the expression of epithelial genes. This evidence concerns the gene GRHL2 and ovarian carcinoma.